The newborn rabbit has been used as a model to investigate the effects of propranolol, the isomers of propranolol, and practolol on the response to cold exposure. Racemic propranolol(1 mg/kg) caused a significant drop in oxygen consumption and higher doses (2.25 and 5.0 mg/kg) abolished the rise caused by cold exposure (Table 1 ). This effect was not mimicked consistently by either the D or I isomer. Practolol had no significant effect at a 1.0 mg/kg dose but in the doses of 2.25 and 5.0 mg/kg completely blocked the cold-induced rise of oxygen consumption. Racemic propranolol caused an increased fall in colonic temperature which was significant when 2.25 mg/kg was used. Neither of the two propranolol isomers nor practolol had a significant effect on colonic temperature (Table 2 ). In contrast, both 2.25 and 5.0 mg/kg racemic propranolol and 2.25 mg/kg practolol caused a significantly greater drop in brown fat temperature than that caused by exposure to 25".
D or I isomer. Practolol had no significant effect at a 1.0 mg/kg dose but in the doses of 2.25 and 5.0 mg/kg completely blocked the cold-induced rise of oxygen consumption. Racemic propranolol caused an increased fall in colonic temperature which was significant when 2.25 mg/kg was used. Neither of the two propranolol isomers nor practolol had a significant effect on colonic temperature (Table 2 ). In contrast, both 2.25 and 5.0 mg/kg racemic propranolol and 2.25 mg/kg practolol caused a significantly greater drop in brown fat temperature than that caused by exposure to 25". The isomers of propranolol did not affect brown fat temperature significantly (Table 3 ). The rise in serum free fatty acid (FFA) concentration induced by cold exposure was reduced or abolished by each drug in every dose used (Table 4 ). The rise in blood glucose due to cold was abolished by racemic propranolol and practolol in all doses used (Table 5) . I-Propranolol significantly inhibited the rise in blood glucose from 60-90 min and caused a fall below the levels seen at 60 min. D-Propranolol had no effect on blood glucose levels. The results show that the fi blockers, propranolol and practolol, seriously compromise the response of the newborn rabbit to thermal stress.
Speculation
Perinatal exposure to fi blockers may compromise the metabolic resDonse of the newborn infant to cold exDosure. The mechanism of action of propranolol in this respect is nbt explained by the sum of the actions of its isomers.
Drugs acting on P adrenoreceptors are now commonly used in clinical obstetric practice (15, 16) . The indications are most commonly to stimulate or inhibit uterine contractions but ,f? blockers are also employed for their effect on the maternal cardiovascular system. The sheep placenta is permeable to propranolol and other ,f? blockers (20) and the human placenta is probably permeable to , B blockers (1, 4). Despite this knowledge that the fetus may be acutely or chronically exposed to such drugs there is little information on the effect of these drugs on the newborn. A case report 9 has suggested that chronic fetal exposure to propranolol may have affected growth as well as having cardiovascular effects (18) .
Interest in drugs acting on adrenergic receptors of adipose tissue in the rabbit stems from the work of Hull (13) , who showed that although pronethalol blocked lipolysis stimulated by isoprenaline or noradrenaline, it was ineffective against cold-induced lipolysis. Subsequently, the role of propranolol in neonatal metabolic homeostasis has been studied in animals (2, 7) and clinically (8) . In the present study we have sought to extend and integrate earlier observations of ,f? blockers on the calorigenic and metabolic response to cold exposure. The results show that both propranolol and practolol seriously compromise the response of the neonate to thermal stress. A preliminary account of part of the work has been published (10, 12) .
MATERIALS AND METHODS

EXPERIMENTAL DESIGN
In all experiments rabbit pups of Dutch stock, 3-7 days of age, were used. The animals were with the mother from birth until 1 hr before the experiment when they were isolated and kept in a thermoneutral environment of 35". In one kind of experiment oxygen consumption and colonic and interscapular brown fat temperature were measured. The animal was placed on a wire grid a few millimeters above the floor in a chamber connected to a closed circuit which included a circulating pump (air flow 2-3 liters/min) and a soda-lime cannister to absorb carbon dioxide and to which oxygen was added to maintain a constant volume and pressure. The characteristics of the circuit have been reported previously in detail (9, 19) . The chamber was placed in a water bath the temperature of which was controlled to within 0.1". Colonic and brown fat temperatures were measured by fine copper-constantan thermocouples (diameter 1 mm, internal resistance 100 ohm) which were inserted 3-5 cm above the anus or placed sc above the interscapular brown adipose tissue. Oxygen consumption and temperature were registered every 2 min and readings taken from the mean of the last 10 min of a 30-min period before a change in experimental condition were used. At this time the measurements were reproducible. The oxygen consumption was corrected to STPD (standard temperature, pressure dry). Readings were made after 30 min at thermoneutrality (Ta 35") then after 30 rnin in a cold environment (Ta 25"). At this point the animal was given an ip injection of a drug and a final reading was made after a further 30 rnin at 25". The drugs used were racemic, D-, or L-propranolol and practolol(22) in doses of 1.0,2.25, and 5.0 mg/kg. The drugs were dissolved in physiologic saline and control animals received saline injections alone. Two types of control experiment were performed. In one the animals were treated exactly as the drug-injected group but were given a saline injection (cold-exposed group), in the other the animals received a saline injection but the chamber temperature was kept at 35" throughout (thermoneutral control group).
In the second type of experiment the animals were anesthetized with ether and the carotid artery was cannulated. The animal was then kept in an open nest, the temperature of which was maintained by a radiant heater at 35" for 30 min. The ambient temperature was then changed to 25" by switching off the radiant heater and switching on a thermocontrolled fan which blew air over the nest for 30 min, after which the animal received an ip injection of one of the drugs or saline, before being returned to the 25" environment for a final 30 min. Blood samples (approximately 0.2 ml) were collected from the cannula into glass capillaries at the time of cannulation (0 min) and after 30, 60, and 90 min. Immediately after the final sample was collected the animal was killed by decapitation and mixed arterial and venous blood was collected from the neck vessels. The patency of the cannula was maintained by filling the dead space with physiologic saline. Blood glucose concentration was estimated by the method of Hultman (14) and serum FFA concentration by the method of Novak (17) .
STATISTICAL ANALYSIS
In both types of experiment sequential measurements were made on the same animal at 30, 60, and 90 min. All results were therefore analyzed for the purposes of comparison between groups as the mean change taking place between 30 and 90 min (effect of temperature change +. drug), and between 60 and 90 min (effect of the drug). Differences in these changes were compared statistically using Student's t-test. Level of significance compared with cold control: P < 0.01 or greater. The mean (kSD) oxygen consumption of all the pups after exposure to 35" for 30 min was 17.4 f 2.6 ml/kg min-l and the range of mean values between different groups was 13.1-18.9 ml/kg min-'. The thermoneutral control group nursed at the same temperature for two further 30-min periods showed no change in oxygen consumption, indicating that the initial measurement was representative of basal conditions and that an ip injection of saline had no effect on oxygen consumption (Table I) , either in the thermoneutral (Ta 35") or cold (Ta 25") environment. The mean oxygen consumption of different groups after exposure to 25" for 30 rnin varied, the range being 31.5-45.0 ml/kg min-', but a second 30 rnin at 25" in the cold control group produced no further rise of oxygen consumption.
Racemic propranolol (1 mg/kg) caused a significant drop in oxygen consumption and higher doses (2.25 and 5.0 mg/kg) abolished the rise caused by cold exposure (Table 1) . This effect was not mimicked consistently by either the D or L isomer, although 2.25 mg/kg L-propranolol did cause a significant inhibition of cold-stimulated oxygen consumption. Practolol had no significant effect at a 1.0 rng/kg dose, but in the doses of 2.25 and 5.0 mg/kg completely blocked the cold-induced rise of oxygen consumption.
COLONIC AND BROWN FAT TEMPERATURE
In the 70 pups used for the measurement of body temperature the mean (+SD) colonic and brown fat temperatures after 30 rnin at 35" were 37.6 + 0.7" and 37.3 + 0.8", respectively. No change in body temperature occurred in the thermoneutral group in the next two 30-min periods from 30-90 min. In the cold control group there was a progressive fall in both colonic and brown fat temperature on exposure to 25" (Tables 2 and 3 ). After 1 hr at 25O the mean (+SEM) brown fat temperature was + 1.5 + 0.4" higher than that in the colon ( n = 8, P < 0.01), indicating a vigorous calorigenesis in this adipose organ, whereas in the thermoneutral control group maintained at 35" the difference was -0.3 f 0. 1" (n = 7, P < 0.01).
Racemic propranolol caused an increased fall in colonic temperature which was significant when 2.25 mg/kg was used. Neither of the two propranolol isomers nor practolol had a significant effect on colonic temperature. In contrast, both 2.25 and 5.0 mg/kg racemic propranolol and 2.25 mg/kg practolol caused a significantly greater drop in brown fat temperature than that caused by exposure to 25". The isomers of propranolol did not affect brown fat temperature signifiantly.
SERUM FFA
The 142 animals used for the measurement of glucose and free fatty concentration had a mean (fSD) body weight of 93.7 + 16.6 g, which was similar to that of those used in the first series of experiments. No association between body weight and the initial circulating levels of FFA or glucose or the response to experimental manipulation was observed.
At the time of cannulation the mean (fSD) serum FFA concentration was 763 f 198 prnol/Iiter, but during the next 30 min no significant change occurred: +12 f 15 pmol/liter (n = 18). The mean (+-SD) serum FFA concentration of all 142 animals after 30 rnin at 35" was 6 19 f 252 pmol/liter, indicating the wide variation in this metabolite which occurred presumably as a result of anesthesia and the cannulation procedure. In the theoneutral control animals there was a further but insignificant increase in the next two 30-min periods, which contrasted with a dramatic doubling of serum FFA concentration in the cold controls when exposed to 25" for 30 rnin (Table 4) . From 60-90 min there was a further small but significant increase in serum FFA in this group.
The rise in serum FFA concentration induced by cold exposure was reduced or abolished by each drug in every dose used. This conclusion is based on the change occurring between 60 and 90 min and caution must be exercised in the analysis of changes occurring between 30 and 90 min since the mean (+SEM) rise of FFA levels in the cold control group on initial exposure to 25" (30-60 min) was +812 f 112 pmol/liter, which was significantly greater than that in 7 of the 11 test groups. The effect of racemic propranolol or practolol on serum FFA levels was dose related, whereas all doses of the propranolol isomers were equipotent. At the end of the experiment the mean (kSEM) difference in serum FFA concentration between mixed blood obtained at decapitation and arterial blood from the cannula was +54 + 17 pmol/liter (n = 27). 
DISCUSSION
The mean (+SD) blood glucose concentration at the time of cannulation was 5.6 + 1.4 mmol/liter ( n = 18). After 30 min at 35" the level had risen insignificantly by +0.3 t 0.2 mmol/liter. However, in the thermoneutral control group the rise continued and was significant in each of the two following 30-min periods (Table 5) . By comparison the rise in the cold control group on initial exposure to 25" for 30 rnin was greater, being +1.8 k 0.2 mmol/liter vs. +0.3 + 0.1 mmol/liter in the thermoneutral control group. A further small but significant rise of +0.3 + 0.1 mmol/liter occurred from 60-90 min in the cold control group. The rise in blood glucose due to cold was abolished by racemic propranolol and practolol in all doses used ( Table 5) . L-Propranolol significantly inhibited the rise in blood glucose from 60-90 rnin and caused a fall below the levels seen at 60 min. D-Propranolol had no effect on blood glucose levels.
CONTROL EXPERIMENTS
The values obtained for the mean and range of observations of oxygen consumption and colonic and brown fat temperature at 35" agree closely with those previously reported by us (6, 7) and other investigators (5). In earlier work there was little standardization of the degree or duration of cold exposure by different authors; however, the increase in oxygen consumption and fall in colonic temperature in the present experiments is similar to that previously observed by us (6, 7) and also by Hardman and Hull (5), who also exposed newborn rabbits of a similar mean weight to 25" for 1 hr. The sustained high oxygen consumption and progressive fall in colonic and brown fat temperature after 30 and 60 rnin at 25" indicate that the animals were hypothermic and, it is assumed, were responding maximally in terms of heat production. The carotid arterial cannulation for blood sampling was essential to permit comparison of values from the same animal, but had the disadvantage of general anesthesia and operative manipulation, both of which are known to raise blood glucose and plasma FFA levels. In fact the progressive rise in the mean blood glucose level of the thermoneutral control group ended at a value which was not significantly different from that found in another group of rabbits, placed alone in chambers at 35" for 3.5 hr, studied earlier by the same workers (2) . Clearly the handling and isolation of a rabbit pup is sufficient stimulus to cause a rise in blood glucose. Anesthesia and operation do not affect blood glucose levels significantly in addition to this. Insignificant changes took place in the mean serum FFA concentration of the thermoneutral control group which were similar to those of the unoperated rabbits referred to above. Cold exposure caused a dramatic rise in serum FFA levels, which has been documented many times, and a rise in blood glucose that was greater than that due to handling, isolation, and anesthesia. These changes were the yardstick against which the effects of the drugs were measured.
DRUG-TREATED ANIMALS
Racemic propranolol and practolol, which is also a racemic compound with molecular weight and pharmacologic properties like those of propranolol, had similar effects in that all doses significantly reduced or abolished the changes in oxygen consumption, serum FFA, and blood glucose caused by cold. These findings are in keeping with our earlier observations that racemic in glycogenolysis and lipolysis (1 1). The effect on oxygen consumption and serum FFA levels was dose related in that a weaker action was seen with 1 mg/kg than with 2.25 or 5.0 mg/kg, but no dose dependence was apparent in the effect on blood glucose levels. Both drugs caused a significantly greater fall in brown fat temperature than was caused by cold alone, but this was not reflected in colonic temverature, which although lower in the stabilizing action but low P-blocking potency (21) , whereas Lpropranolol has both a P-blocking and membrane-stabilizing action (3). The fall in blood glucose and serum FFA caused by Lpropranolol confirms our earlier findings at both 35" and 25" (2, 1 l), and may be explained on the basis of the P-blocking action. The effect of D-propranolol in lowering the serum FFA significantly at Ta 25" was compatible with the result of earlier work (2) in which a small insignificant reduction was observed when the dose of 1 mg/kg was employed. It is not possible to propose a mechanism of action, however, since at 35", 1 mg/kg D-propran-0101 caused a rise in mean serum FFA and blood glucose concentration (2). It is noteworthy that neither isomer even at the highest dose had a significant effect on oxygen consumption or brown fat temperature, whereas when acting together at half that dose in the form of the racemer, there was a profound effect.
GENERAL
The present experiments have demonstrated clearly that the ,8-blocker drugs propranolol and practolol can abolish the ability of newborn rabbits to respond to a cold stress. Despite the use of an animal model these findings have direct clinical relevance since infants are born who have been exposed to , 8 blockers in utero or who may require such drugs as treatment in the neonatal period. The dosage range used in the animal experiments was defined in earlier experiments on the basis of cardiovascular effects (2). Although it was much greater than that recommended for parenteral administration to the human infant (0.02-0.1 mg/kg/dose) it was comparable to that recommended for oral therapy (0.5-1.0 mg/kg/dose). Inasmuch as little is known about accumulation of maternally administered /3 blockers in the human fetus or about their pharmacology in the newborn, we consider that our findings should be taken as a warning that such infants may respond subnormally to cold stress and show other abnormalities of metabolic homeostasis. If this risk is appreciated, appropriate care and precautions can be taken. drug-treated animals, wa's not significantly less &an the level in the control group.
